Jan. 26, 2024
by Andrii Buvailo, PhD
Biopharma insight
The year 2024 has ushered in a new wave of excitement in the biotech industry, with several promising companies making …
Jan. 12, 2024
by Dana Sokolova
Biopharma insight
In 2023, the venture capital (VC) landscape witnessed significant activity, providing crucial support to the biotech sector amidst a volatile …
March 5, 2024
by Andrii Buvailo, PhD
News
Elsevier, a global provider of information and analytics in science and health with 140 years of history, has entered into …
Feb. 2, 2024
by News Team
News
Aqemia, a Paris-based biotech startup, raised an additional €30 million in a Series A funding extension, totaling €60 million in …
June 16, 2023
by Irina Bilous
Biopharma insight
IgGenix, Inc., a California-based preclinical antibody discovery and development company, recently reported advances towards a potential therapeutic solution for peanut …
Feb. 28, 2024
by Andrii Buvailo, PhD
News
It is a remarkable day for Ginkgo Bioworks, a notable player in the field of synthetic biology, as the company …
Jan. 3, 2024
by Dana Sokolova
News
Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated …
March 11, 2024
by Andrii Buvailo, PhD
News
Recursion (NASDAQ: RXRX), a clinical-stage TechBio company, has unveiled plans to establish a new office in London's King’s Cross area, …
March 25, 2024
by Andrii Buvailo, PhD
Biopharma insight
The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021. …
Feb. 7, 2024
by Roman Kasianov
News
Exscientia plc, a UK-based AI-driven precision medicine company, has initiated a clinical study, EXCYTE-2, focusing on acute myeloid leukaemia (AML) patients. …
Jan. 15, 2024
by Roman Kasianov
News
Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
As we stand at the crossroads of artificial intelligence (AI) and biotech, what future awaits protein design, and how are …